Join

Compare · CHNA vs HCXY

CHNA vs HCXY

Side-by-side comparison of Loncar China BioPharma ETF (CHNA) and Hercules Capital, Inc. (HCXY): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CHNA and HCXY operate in n/a (n/a), so they compete in similar markets.
  • HCXY carries a market cap of $4.53B.
  • HCXY has hit the wire 2 times in the past 4 weeks while CHNA has been quiet.
MetricCHNAHCXY
Company
Loncar China BioPharma ETF
Hercules Capital, Inc.
Price
$14.28-0.56%
$24.77-0.96%
Market cap
-
$4.53B
1M return
-
-1.04%
1Y return
-
-0.40%
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NYSE
IPO
n/a
2018
News (4w)
0
2
Recent ratings
0
0
CHNA

Loncar China BioPharma ETF

The investment seeks to track the performance, before fees and expenses, of the Loncar China BioPharma Index (the index). Under normal circumstances, at least 80% of the fund's total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the index or in depositary receipts representing such component securities. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries. The fund is non-diversified.

Latest CHNA

No recent items for Loncar China BioPharma ETF.

Latest HCXY